S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal ArticleDOI
Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy
Marja-Riitta Taskinen,William F. Beltz,Ingeborg T. Harper,Rose M. Fields,Gustav Schonfeld,Scott M. Grundy,Barbara V. Howard +6 more
TL;DR: The data indicate there are multiple abnormalities in structure and metabolism of VLDL in non-insulin-dependent diabetics and control of hyperglycemia with sulfonylureas has the capability of reversing some of these abnormalities.
Journal ArticleDOI
Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans
TL;DR: It is concluded that cocoa products supplementation in humans affects LDL oxidizability, but not urinary F(2) isoprostanes or markers of inflammation, and there was no effect of chocolate on urinary F (2) wasoprostane levels or on markers ofinflammation.
Prevention Conference V Beyond Secondary Prevention: Identifying the High-Risk Patient for Primary Prevention Medical Office Assessment
Scott M. Grundy,Terry L. Bazzarre,James I. Cleeman,Martha N. Hill,Nancy Houston-Miller,William B. Kannel,Ronald M. Krauss,Harlan M. Krumholz,Ronald M. Lauer,Ira S. Ockene,Richard C. Pasternak,Thomas A. Pearson,Paul M. Ridker,Darien Wood +13 more
TL;DR: The role of medical office assessment in the detection of risk factors and estimation of total cardiovascular risk was discussed in this article, with the primary focus on identification of known risk factors for coronary heart disease (CHD).
Journal ArticleDOI
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Emerging Biomarkers for Primary Prevention of Cardiovascular Disease
Gary L. Myers,Robert H. Christenson,Mary Cushman,Christie M. Ballantyne,Gerald R. Cooper,Christine M. Pfeiffer,Scott M. Grundy,Darwin R. Labarthe,Daniel Levy,Nader Rifai,Peter W.F. Wilson +10 more
TL;DR: Only high sensitivity C-reactive protein (hsCRP) met all of the stated criteria required for acceptance as a biomarker for risk assessment in primary prevention.
Journal ArticleDOI
Cholesterol metabolism in hypothyroidism and hyperthyroidism in man
TL;DR: No evidence was obtained in either hypothyroid or hyperthyroid patients that thyroid hormones alter synthesis of bile acids, and on the other hand, the hormones appeared to increase the synthesis of cholesterol.